CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1 | -100.0% | 20,200 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $24,000 | -33.3% | 20,200 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $36,000 | -10.0% | 20,200 | +2.5% | 0.00% | 0.0% |
| Q1 2022 | $40,000 | -25.9% | 19,700 | -0.8% | 0.00% | 0.0% |
| Q4 2021 | $54,000 | -52.2% | 19,850 | -21.7% | 0.00% | -60.0% |
| Q3 2021 | $113,000 | -17.5% | 25,350 | +7.6% | 0.01% | -16.7% |
| Q2 2021 | $137,000 | -0.7% | 23,550 | +19.8% | 0.01% | -25.0% |
| Q1 2021 | $138,000 | +62.4% | 19,650 | +10.7% | 0.01% | +14.3% |
| Q4 2020 | $85,000 | -8.6% | 17,750 | +11.3% | 0.01% | -22.2% |
| Q3 2020 | $93,000 | +6.9% | 15,950 | +23.2% | 0.01% | +12.5% |
| Q2 2020 | $87,000 | – | 12,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |